ROYAL BANK OF CANADA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 70 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$6,000
-87.2%
435
-87.5%
0.00%
Q4 2023$47,000
+193.8%
3,488
+160.1%
0.00%
Q3 2023$16,000
+6.7%
1,341
+6.9%
0.00%
Q2 2023$15,0001,255
+15587.5%
0.00%
Q1 2023$080.0%0.00%
Q4 2022$0
-100.0%
8
-99.8%
0.00%
Q3 2022$13,000
-38.1%
3,539
+0.9%
0.00%
Q2 2022$21,000
-4.5%
3,5080.0%0.00%
Q1 2022$22,000
+57.1%
3,508
-0.3%
0.00%
Q4 2021$14,000
+40.0%
3,517
+75.1%
0.00%
Q3 2021$10,000
-23.1%
2,0080.0%0.00%
Q2 2021$13,0000.0%2,0080.0%0.00%
Q1 2021$13,0002,008
+3485.7%
0.00%
Q4 2020$0
-100.0%
56
-79.8%
0.00%
Q3 2020$1,0000.0%277
-13.2%
0.00%
Q2 2020$1,000319
-17.4%
0.00%
Q1 2020$0386
+72.3%
0.00%
Q4 2019$0
-100.0%
224
+32.5%
0.00%
Q3 2019$1,0000.0%169
+9.0%
0.00%
Q2 2019$1,0000.0%1550.0%0.00%
Q1 2019$1,0000.0%1550.0%0.00%
Q4 2018$1,000
-99.7%
155
-99.8%
0.00%
Q3 2018$378,000
+5.9%
70,812
-2.6%
0.00%
Q2 2018$357,000
-38.8%
72,735
+0.3%
0.00%
Q1 2018$583,000
-19.6%
72,492
+2.5%
0.00%
Q4 2017$725,000
-30.7%
70,755
-1.7%
0.00%
-100.0%
Q3 2017$1,046,00071,9760.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Rise Advisors, LLC 272$4,1080.00%
DIMENSIONAL FUND ADVISORS LP 318,995$4,826,3940.00%
Covestor Ltd 106$00.00%
Farther Finance Advisors, LLC 77$00.00%
JBF Capital, Inc. 39,637$1,1890.00%
GOLDMAN SACHS GROUP INC 29,807$450,9800.00%
NISA INVESTMENT ADVISORS, LLC 15$00.00%
CWM, LLC 22$00.00%
CALDWELL SUTTER CAPITAL, INC. 7,458$00.00%
RHUMBLINE ADVISERS 2,480$37,5190.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders